Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 0.9100
-0.0900 (-9.00%)
At close: Jun 30, 2026
Sharp Therapeutics Market Cap
Sharp Therapeutics has a market cap or net worth of CAD 27.37 million as of August 10, 2026. Its market cap has increased by 82.63% in one year.
Market Cap
27.37M
Enterprise Value
27.82M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.91
ChartMarket Cap Chart
Since January 17, 2025, Sharp Therapeutics's market cap has decreased from 62.09M to 27.37M, a decrease of -55.92%. That is a compound annual growth rate of -43.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 27.37M | -63.52% |
| Dec 30, 2025 | 75.03M | 20.85% |
| Jan 17, 2025 | 62.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 39.95M |
| Medicenna Therapeutics | 36.00M |
| Telescope Innovations | 34.76M |
| Resverlogix | 32.66M |
| Sona Nanotech | 32.03M |
| Defence Therapeutics | 30.32M |
| Thiogenesis Therapeutics | 28.51M |
| Quantum BioPharma | 28.15M |